Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Evofem Biosciences, Inc. (EVFM) had Receiveable Turnover of 1.97 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$19.36M |
|
$-8.96M |
|
$3.83M |
|
$15.53M |
|
$27.04M |
|
$-7.68M |
|
$-1.18M |
|
$-8.86M |
|
$-8.86M |
|
$-8.86M |
|
$-8.86M |
|
$-8.86M |
|
$-8.86M |
|
$-7.68M |
|
$-7.03M |
|
75.20M |
|
75.20M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$13.61M |
|
$0.46M |
|
$10.18M |
|
$23.79M |
|
$80.45M |
|
-- |
|
$9.82M |
|
$90.26M |
|
$-71.26M |
|
$-76.07M |
|
$-66.47M |
|
113.36M |
|
| Cash Flow Statement Financials | |
$-3.88M |
|
$-0.57M |
|
$4.62M |
|
$0.58M |
|
$0.74M |
|
$0.16M |
|
$0.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.17 |
|
-- |
|
-- |
|
-- |
|
-0.69 |
|
80.20% |
|
-39.64% |
|
-39.64% |
|
-36.29% |
|
-45.76% |
|
-46.30% |
|
$-4.45M |
|
-- |
|
-- |
|
-- |
|
0.81 |
|
2.43 |
|
|
Receiveable Turnover |
1.97 |
185.34 |
|
12.43% |
|
11.65% |
|
-37.24% |
|
13.33% |
|
$-0.59 |
|
$-0.06 |
|
$-0.05 |
|